Page 25 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ExodusPoint Capital Management LP bought a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the second quarter, HoldingsChannel reports. The firm bought 62,839 shares of the biotechnology company’s stock, valued at approximately $646,000. A number of other hedge funds and other institutional investors have also recently modified their holdings […]

Mustang Bio (NASDAQ:MBIO – Get Free Report) and Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Valuation and Earnings This table compares […]

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw strong trading volume on Wednesday . 620,360 shares traded hands during mid-day trading, an increase of 129% from the previous session’s volume of 271,139 shares.The stock last traded at $15.96 and had previously closed at $15.07. Analyst Upgrades and Downgrades A number of […]

/PRNewswire/ -- Inherited types of anemia encompass a group of genetic disorders characterized by a deficiency in the production, structure, or function of...

Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company...